[HTML][HTML] Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada

…, JRB Dyck, S Klarenbach, L Richer, E Jess… - BMC Public Health, 2021 - Springer
Background The opioid overdose epidemic in Canada and the United States has become a
public health crisis - with exponential increases in opioid-related morbidity and mortality. …

Characterisation of concurrent use of prescription opioids and benzodiazepine/Z-drugs in Alberta, Canada: a population-based study

…, D Weir, S Samanani, SH Simpson, F Gilani, E Jess… - BMJ open, 2019 - bmjopen.bmj.com
Objective The objective of this study is to characterise concurrent use of benzodiazepine
receptor modulators and opioids among prescription opioid users in Alberta in 2017. Design A …

Concurrent use of opioids and benzodiazepines/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study

V Sharma, SH Simpson, S Samanani, E Jess… - BMJ open, 2020 - bmjopen.bmj.com
Objectives Coprescribing of benzodiazepines/Z-drugs (BZDs) and opioids is a drug-use
pattern of considerable concern due to risk of adverse events. The objective of this study is to …

[HTML][HTML] Reducing prescribing of benzodiazepines in older adults: a comparison of four physician-focused interventions by a medical regulatory authority

…, N Kain, D Wiebe, N Hernandez-Ceron, E Jess… - BMC family …, 2021 - Springer
Background The inappropriate and/or high prescribing of benzodiazepine and ‘Z’ drugs (BDZ
+) is a major health concern. The purpose of this study was to determine whether …

Development and validation of a machine learning model to estimate risk of adverse outcomes within 30 days of opioid dispensation

V Sharma, V Kulkarni, E Jess, F Gilani… - JAMA Network …, 2022 - jamanetwork.com
Importance Machine learning approaches can assist opioid stewardship by identifying high-risk
opioid prescribing for potential interventions. Objective To develop a machine learning …

[HTML][HTML] Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada

…, JRB Dyck, SW Klarenbach, L Richer, E Jess… - BMC Public Health, 2024 - Springer
Background Benzodiazepines are a class of medications that are being frequently prescribed
in Canada but carry significant risk of harm. There has been increasing clinical interest on …

Defining opioid naïve and implications for monitoring opioid use: A population‐based study in Alberta, Canada

C Lee, M Ye, O Weaver, E Jess, F Gilani… - … and drug safety, 2024 - Wiley Online Library
Purpose Reducing initial exposure of “opioid naïve” patients to opioids is a public health
priority. Identifying opioid naïve patients is difficult, as numerous definitions are used. The …

[HTML][HTML] Benzodiazepine receptor agonist dispensations in Alberta: a population-based descriptive study

DL Weir, S Samanani, F Gilani, E Jess… - … Open Access Journal, 2018 - cmajopen.ca
Background: There is increasing concern over the use of benzodiazepine receptor agonists
(BZRAs). The objective of this study was to describe BZRA dispensations in the province of …

Survey of physician attitudes to using multisource feedback for competence assessment in Alberta

N Ashworth, NA Kain, E Jess, K Mazurek - BMJ open, 2020 - bmjopen.bmj.com
Background The use of multisource feedback (MSF) for assessing physician performance is
widespread and rapidly growing. Findings from early very small research studies using …

[HTML][HTML] Medical cannabis authorization in patients with cancer in the prelegalization era: A population-based study

S Karim, WY Cheung, J Bu, E Jess, M Kerba - Journal of Pain and Symptom …, 2020 - Elsevier
Context Studies show that patients with cancer use cannabis to manage symptoms and side
effects. Medical cannabis is regulated by Health Canada; authorization patterns among …